Clinical Trial: Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thrombotic Microangiopathies
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Narsoplimab in Pediatric Patients (28 Days to ? 18 Years of Age.) With High-Risk Hematopoietic Stem Cell Tran
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematopoietic stem cell transplant (HSCT).
Read more